Mateja is an experienced senior executive in the pharmaceutical industry and one of the first and most influential leaders in the field of Biosimilars on a global scale. As a global manager at Sandoz, she played a key role in the creation of specific EMA and FDA regulations and the introduction of biosimilars into clinical practice in the EU and the US. At the same time, she laid the foundation for Sandoz/Lek Biopharmaceuticals – the first biopharmaceuticals team with development laboratories for recombinant technologies and production facility for cell culture biologics in Slovenia and CEE at that time.
For the past decade, she provides business services to leading global pharmaceutical and biotechnology companies in the area of innovative technologies in healthcare, mostly focused on biopharmaceuticals and cell & gene therapies.